In the subgroup analysis by cancer type, we found a significant association between MnSOD Val16Ala polymorphism and elevated prostate cancer risk, and no significant association between this polymorphism and breast cancer, which were consistent with previous meta-analyses [131, 134–137]. The gene discussed is SOD2; the disease is prostate cancer.